Description
Argatrobanisanantithrombotic/anticoagulantcompoundthatinhibitsthrombin.Argatrobanisclinicallyusedtotreatthrombosisandacutecoronarysyndrome.
Argatrobanisanantithrombotic/anticoagulantcompoundthatinhibitsthrombin.Argatrobanisclinicallyusedtotreatthrombosisandacutecoronarysyndrome.
CasNo. | 74863-84-6 |
---|---|
Purity | ≥98% |
Formula | C23H36N6O5S |
FormulaWt. | 508.64 |
ChemicalName | (2R,4R)-4-Methyl-1-((S)-N(sup2)-(((RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl)sulfonyl)arginyl)-pipecolicacid |
IUPACName | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylicacid |
Synonym | Argatrobanum |
MeltingPoint | 188-191°C |
Solubility | Solubleinethanol. |
Appearance | WhiteCrystallinePowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
MSDS | A6823MSDSPDF |
---|---|
InfoSheet | A6823InfoSheetPDF |
Tardy-PoncetB,CombeM,PiotM,etal.Effectsofargatroban,danaparoid,andfondaparinuxontrombingenerationinheparin-inducedthrombocytopenia.ThrombHaemost.2013Mar;109(3):504-9.PMID:23328916.
Cruz-GonzálezI,López-JiménezR,Perez-RiveraA,etal.Pharmacokineticevaluationofargatrobanforthetreatmentofacutecoronarysyndrome.ExpertOpinDrugMetabToxicol.2012Nov;8(11):1483-93.PMID:22970706.